Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Amfonelic Acid
AOB5287
CAS No: 15180-02-6
Chemical Name: 7-Benzyl-1-ethyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
424 Items
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $50.15 | Total: $250.75 |
| 1 | 10 | $42.48 | Total: $424.80 |
| 1 | 25 | $35.99 | Total: $899.75 |
| 1 | 50 | $30.68 | Total: $1,534.00 |
| 1 | 100 | $26.55 | Total: $2,655.00 |
Overview
A research chemical with highly selective dopaminergic stimulant and antibiotic properties.
What is Amfonelic Acid?
Amfonelic acid is a research chemical and a dopaminergic stimulant. Wikipedia+2OUP Academic+2
It is a potent and selective dopamine reuptake inhibitor (DRI), meaning it blocks the reabsorption of dopamine into neurons, increasing its availability in the synaptic cleft. OUP Academic+3Wikipedia+3ScienceDirect+3
It appears to have minimal activity (or no direct effect) on noradrenaline (norepinephrine) reuptake or release. Wikipedia+3OUP Academic+3ScienceDirect+3
Some sources also mention it has antibiotic properties (likely as a chemical curiosity or off-target effect) though its primary interest is in neuroscience research. Wikipedia+1
Pharmacodynamics / Mechanism of Action
Because it blocks the dopamine transporter (DAT), it increases extracellular dopamine levels, enhancing dopaminergic signaling. Wikipedia+3ScienceDirect+3OUP Academic+3
It has been described as being more potent (in certain assays) than methylphenidate (in rat brain preparations) by a substantial margin. Wikipedia+2ScienceDirect+2
In animal behavioral paradigms, it shows stimulant effects (increasing locomotor activity, etc.) and can substitute (in discrimination tasks) for dextroamphetamine, with even greater potency in some cases. OUP Academic+3Wikipedia+3ScienceDirect+3
It has a moderately long half-life in some studies (~12 hours in certain rat brain models) which supports sustained dopaminergic action. Wikipedia
Observed Effects in Animal Studies
Neuroprotection: In a rat model, when given concurrently with methamphetamine (which can damage dopaminergic terminals), amfonelic acid was able to prevent or attenuate much of the dopaminergic terminal degeneration and loss of dopamine content. PubMed
Behavioral sensitization / chronic effects: Repeated dosing of stimulants (including amfonelic acid) can lead to a sensitized behavioral response (i.e. more pronounced effects upon re-exposure). SpringerLink+1
Neurochemical changes: Chronic or repeated exposure can lead to changes in serotonergic systems (reductions in 5-HT and its metabolite 5-HIAA), even though amfonelic acid is not directly acting on serotonin systems. SpringerLink+2ScienceDirect+2
Reward / threshold effects: It can lower the threshold for reward in some paradigms, meaning less stimulation is needed to produce rewarding (reinforcing) effects. ScienceDirect
Limitations, Risks, and Unknowns
Very limited human / clinical trial data exist (if any). Most of the data are in animals. Wikipedia+1
Because it’s a potent dopamine modulator, it carries risks typical of stimulants (e.g. potential for abuse, neurotoxicity under some conditions) — though direct evidence in humans is lacking.
The long-term effects (neurochemical adaptations, receptor changes, downregulation, etc.) are not well characterized.
The antibiotic claim is less well characterized and likely not its primary mode of interest in neuroscience research.
It is used “for research purposes only” and is not approved for therapeutic use.
Chemical Properties
| Molecular Formula | C18H16N2O3 |
| Molecular Weight | 308.33 |
| CAS Numbers | 15180-02-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| IUPAC/Chemical Name | 7-Benzyl-1-ethyl-4-oxo-1,8-naphthyridine-3-carboxylic acid |
| InChl Key | WHHHJDGNBVQNAU-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C18H16N2O3/c1-2-20-11-15(18(22)23)16(21)14-9-8-13(19-17(14)20)10-12-6-4-3-5-7-12/h3-9,11H,2,10H2,1H3,(H,22,23) |
| SMILES Code | O=C(C1=CN(CC)C2=NC(CC3=CC=CC=C3)=CC=C2C1=O)O |
Storage and Handling
0°C (short term), -20°C (long term), desiccated
Synonyms
WIN-25978
References
1) Cox ET, et al., Combined norepinephrine/serotonergic reuptake inhibition: effects on maternal behavior, aggression, and oxytocin in the rat. Front Psychiatry. 2011 Jun 8;2:34. doi: 10.3389/fpsyt.2011.00034. eCollection 2011. PubMed PMID: 21713063; PubMed Central PMCID: PMC3114092.
2) Bongiovanni R, Young D, Newbould E, Jaskiw GE. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine. Brain Res. 2006 Oct 18;1115(1):26-36. Epub 2006 Aug 24. PubMed PMID: 16934236.
